2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P1] Poster Session 1 Hematologic Malignancies 1

Anik R. Patel1, Brad Kahl2, Adriana Wiesinger1, Binu Gurung3, Eve H. Limbrick-Oldfield4, Akshay Sudhindra1, Julia Thornton Snider1, Steve Kanters4 (1.Kite, a Gilead Company, Santa Monica, CA, USA, 2.Oncology Division, Department of Medicine, Washington University School of Medicine in St. Louis, MO, USA, 3.Health Economics & Outcomes Research, IQVIA, London, UK, 4.RainCity Analytics, Vancouver, BC, Canada)

Kenshi Suzuki1, Amy Buchanan-Hughes2, Alvin Ng3, Yan Ran Wee3, Iro Chatzidaki4, Jose Garnica5, Eiji Kawahara6, Fumiko Ueki6, Christopher Kim7, Nicholas Despiegel7 (1.Japanese Red Cross Medical Center, Tokyo, Japan, 2.Costello Medical, Boston, MA, USA, 3.Costello Medical, Singapore, Singapore, 4.Costello Medical, London, UK, 5.Kite Pharma, Santa Monica, CA, USA, 6.Amgen K. K., Tokyo, Japan, 7.Amgen, CA, USA)